These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 11395245

  • 1. Long-term cerebral metabolite changes on proton magnetic resonance spectroscopy in patients cured of acute lymphoblastic leukemia with previous intrathecal methotrexate and cranial irradiation prophylaxis.
    Chan YL, Roebuck DJ, Yuen MP, Yeung KW, Lau KY, Li CK, Chik KW.
    Int J Radiat Oncol Biol Phys; 2001 Jul 01; 50(3):759-63. PubMed ID: 11395245
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the late effects of CNS prophylactic treatment in childhood acute lymphoblastic leukemia (ALL) using magnetic resonance spectroscopy.
    Ficek K, Blamek S, Syguła D, Miszczyk L, Sońta-Jakimczyk D, Tarnawski R.
    Acta Neurochir Suppl; 2010 Jul 01; 106():195-7. PubMed ID: 19812948
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
    Hill JM, Kornblith AB, Jones D, Freeman A, Holland JF, Glicksman AS, Boyett JM, Lenherr B, Brecher ML, Dubowy R, Kung F, Maurer H, Holland JC.
    Cancer; 1998 Jan 01; 82(1):208-18. PubMed ID: 9428499
    [Abstract] [Full Text] [Related]

  • 4. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE, Carlos RC, Smith EA, Frechtling D, George B, Maly P, Sundgren PC.
    Acad Radiol; 2011 Sep 01; 18(9):1101-8. PubMed ID: 21820634
    [Abstract] [Full Text] [Related]

  • 5. Long-term Brain Tissue Monitoring after Semi-brain Irradiation in Rats Using Proton Magnetic Resonance Spectroscopy: A Preliminary Study In vivo.
    Chen H, Cheng YS, Zhou ZR.
    Chin Med J (Engl); 2017 Apr 20; 130(8):957-963. PubMed ID: 28397726
    [Abstract] [Full Text] [Related]

  • 6. Proton magnetic resonance spectroscopy ((1)H-MRS) of the brain following high-dose methotrexate treatment for childhood cancer.
    Davidson A, Payne G, Leach MO, McVicar D, Britton JM, Watson M, Tait DM.
    Med Pediatr Oncol; 2000 Jul 20; 35(1):28-34. PubMed ID: 10881004
    [Abstract] [Full Text] [Related]

  • 7. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
    Raizer JJ, Koutcher JA, Abrey LE, Panageas KS, DeAngelis LM, Lis E, Xu S, Zakian KL.
    J Neurooncol; 2005 Jan 20; 71(2):173-80. PubMed ID: 15690135
    [Abstract] [Full Text] [Related]

  • 8. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Zeng QS, Li CF, Zhang K, Liu H, Kang XS, Zhen JH.
    J Neurooncol; 2007 Aug 20; 84(1):63-9. PubMed ID: 17619225
    [Abstract] [Full Text] [Related]

  • 9. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M, Reiter A, Henze G, Niemeyer C, Bode U, Kühl J, Gadner H, Havers W, Plüss H, Kornhuber B, Zintl F, Ritter J, Urban C, Niethammer D, Riehm H.
    Klin Padiatr; 1998 Aug 20; 210(4):192-9. PubMed ID: 9743952
    [Abstract] [Full Text] [Related]

  • 10. [Brain metabolic disorders after chemotherapy in the study by magnetic resonance spectroscopy].
    Ciszkowska-Łysoń B, Królicki L, Teska A, Janowicz-Zebrowska A, Krzakowski M, Tacikowska M.
    Neurol Neurochir Pol; 2003 Aug 20; 37(4):783-98. PubMed ID: 14746239
    [Abstract] [Full Text] [Related]

  • 11. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy.
    Estève F, Rubin C, Grand S, Kolodié H, Le Bas JF.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):279-86. PubMed ID: 9457810
    [Abstract] [Full Text] [Related]

  • 12. Impaired brain metabolism and neurocognitive function in childhood leukemia survivors despite complete hormone supplementation in adulthood.
    Follin C, Erfurth EM, Johansson A, Lätt J, Sundgren PC, Österberg K, Spulber G, Mannfolk P, Björkman-Burtscher IM.
    Psychoneuroendocrinology; 2016 Nov 15; 73():157-165. PubMed ID: 27498291
    [Abstract] [Full Text] [Related]

  • 13. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ, Kennedy K, Maze R, Greenberg ML, Weitzman S, Hitzler JK, Nathan PC.
    J Clin Oncol; 2006 Aug 20; 24(24):3858-64. PubMed ID: 16921038
    [Abstract] [Full Text] [Related]

  • 14. Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.
    Kähkönen M, Metsähonkala L, Minn H, Utriainen T, Korhonen T, Norvasuo-Heilä MK, Harila-Saari A, Aärimaa T, Suhonen-Polvi H, Ruotsalainen U, Solin O, Salmi TT.
    Cancer; 2000 Feb 01; 88(3):693-700. PubMed ID: 10649265
    [Abstract] [Full Text] [Related]

  • 15. Magnetic resonance spectroscopic evaluation of brain tissue metabolism after irradiation for pediatric brain tumors in long-term survivors: a report of two cases.
    Blamek S, Wydmański J, Sokół M, Matulewicz L, Boguszewicz L.
    Acta Neurochir Suppl; 2010 Feb 01; 106():191-4. PubMed ID: 19812947
    [Abstract] [Full Text] [Related]

  • 16. Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group.
    Tsurusawa M, Katano N, Yamamoto Y, Hirota T, Koizumi S, Watanabe A, Takeda T, Hatae Y, Yatabe M, Mimaya J, Gushiken T, Nishi K, Anami K, Kikuta A, Kanegane H, Asami K, Nishikawa K, Sekine I, Kawano Y, Iwai A, Furuyama T, Ijichi O, Miyake M, Mugishima H, Fujimoto T.
    Med Pediatr Oncol; 1999 Apr 01; 32(4):259-6. PubMed ID: 10102019
    [Abstract] [Full Text] [Related]

  • 17. Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy--an MR analysis.
    Matsumoto K, Takahashi S, Sato A, Imaizumi M, Higano S, Sakamoto K, Asakawa H, Tada K.
    Int J Radiat Oncol Biol Phys; 1995 Jul 15; 32(4):913-8. PubMed ID: 7607965
    [Abstract] [Full Text] [Related]

  • 18. Noninvasive evaluation of radiation-enhanced glioma cells invasiveness by ultra-high-field (1)H-MRS in vitro.
    Xu YJ, Cui Y, Li HX, Shi WQ, Li FY, Wang JZ, Zeng QS.
    Magn Reson Imaging; 2016 Oct 15; 34(8):1121-7. PubMed ID: 27215950
    [Abstract] [Full Text] [Related]

  • 19. CNS prophylaxis of childhood leukemia: what are the long-term neurological, neuropsychological, and behavioral effects?
    Stehbens JA, Kaleita TA, Noll RB, MacLean WE, O'Brien RT, Waskerwitz MJ, Hammond GD.
    Neuropsychol Rev; 1991 Jun 15; 2(2):147-77. PubMed ID: 1844707
    [Abstract] [Full Text] [Related]

  • 20. Brain magnetic resonance spectroscopy (MRS) as a diagnostic tool for detecting early neurological changes in children with Wilson's disease.
    Alkhalik Basha MA, Refaat R, Ahmed AF, Yousef HY, Alsowey AM, Metwally MI, Aly SA, Hussien HM, El-Saadany HF, AlGhobashy AA, Talat MA, Amer MM, Eid AM.
    Eur J Radiol; 2019 Feb 15; 111():41-46. PubMed ID: 30691663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.